Article
Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Scandinavian journal of infectious diseases. Supplementum - 1 Jan 2003
Narciso Pasquale, Lazzarin Adriano
Abstract excerpt
Witness for the prosecution: Assays to detect antiretroviral drug resistance have recently become available, but several factors limit the clinical utility of resistance testing in patients with primary HIV infection (PHI). First, there is a great uncertainty in the prevalence of PHI due to resistant virus, which may vary from 2% to over 50%. Moreover, studies on temporal trends give discordant results. Secondly,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
